
    
      Participants are randomly devided into 'G-POEM group' and 'Esomeprazole+Mosapride group'. In
      G-POEM group, each participant receives G-POEM treatment. In Esomeprazole+Mosapride group,
      each participant receives Nexium 40mg bid + Mosapride Citrate Tablets 5mg tid. The whole
      outcome measure time fram is up to two years. Outcome evaluations include: gastric emptying
      imaging, gastric antrum volume, gastric emptying time, gastroparesis cardinal symptoms index
      and gastroesophageal reflux disease questionnaire. All the outcomes are assessed at different
      time points (from baseline to 6 months, 12months and 24months).
    
  